Evaluation of the adult patient with atopic dermatitis

Clinical and Experimental Allergy

Volumn 43, Issue 3, 2013, Pages 279-291

  De Bruin Weller, M S ^a   Rockmann, H ^a   Knulst, A C ^a   Bruijnzeel Koomen, C A F M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FOOD ALLERGEN; HYDROCORTISONE BUTYRATE; STEROID;

ALLERGIC CONJUNCTIVITIS; APPLE; ASTHMA; ATOPIC DERMATITIS; ATOPIC KERATOCONJUNCTIVITIS; BONE DENSITY; CARROT; CELERY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EOSINOPHILIC ESOPHAGITIS; FOOD ALLERGY; HAZELNUT; HERPES SIMPLEX VIRUS; HUMAN; MALASSEZIA SYMPODIALIS; PATIENT ASSESSMENT; PHOTOSENSITIVITY; PRICK TEST; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RHINITIS; STAPHYLOCOCCUS AUREUS; STEROID THERAPY; ULTRAVIOLET RADIATION;

ADULT; BONE DENSITY; COMORBIDITY; DERMATITIS, ATOPIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; QUALITY OF LIFE; RISK FACTORS; VITAMIN D;

EID: 84873953739     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12030     Document Type: Review

References (104)

1. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994; 30:35-9.
2. Herd RM, Tidman MJ, Prescott RJ, Hunter JA. Prevalence of atopic eczema in the community: the Lothian Atopic Dermatitis study. Br J Dermatol 1996; 135:18-9.
3. Vartiainen E, Petays T, Haahtela T, Jousilahti P, Pekkanen J. Allergic diseases, skin prick test responses, and IgE levels in North Karelia, Finland, and the Republic of Karelia, Russia. J Allergy Clin Immunol 2002; 109:643-8.
4. Finlay AY. Quality of life in atopic dermatitis. J Am Acad Dermatol 2001; 45(Suppl. 1):S64-6.
5. Folster-Holst R, Pape M, Buss YL, Christophers E, Weichenthal M. Low prevalence of the intrinsic form of atopic dermatitis among adult patients. Allergy 2006; 61:629-32.
6. Schmid-Grendelmeier P, Simon D, Simon HU, Akdis CA, Wuthrich B. Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001; 56:841-9.
7. Akdis CA, Akdis M. Immunological differences between intrinsic and extrinsic types of atopic dermatitis. Clin Exp Allergy 2003; 33:1618-21.
8. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004; 113:651-7.
9. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 2003; 112(Suppl. 6):S118-27.
10. Calonge M. Ocular allergies: association with immune dermatitis. Acta Ophthalmol Scand Suppl 2000; 230:69-75.
11. Brandonisio TM, Bachman JA, Sears JM. Atopic dermatitis: a case report and current clinical review of systemic and ocular manifestations. Optometry 2001; 72:94-102.
12. Liacouras CA, Furuta GT, Hirano I et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128:3-20.
13. Darsow U, Wollenberg A, Simon D et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24:317-28.
14. Akdis CA, Akdis M, Bieber T et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 2006; 118:152-69.
15. Katsarou A, Armenaka M. Atopic dermatitis in older patients: particular points. J Eur Acad Dermatol Venereol 2011; 25:12-8.
16. Tanei R, Katsuoka K. Clinical analyses of atopic dermatitis in the aged. J Dermatol 2008; 35:562-9.
17. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92(Suppl.):44-7.
18. Williams HC, Burney PG, Pembroke AC, Hay RJ. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. U.K. Diagnostic Criteria for Atopic Dermatitis Working Party. Br J Dermatol 1996; 135:12-7.
19. Asher MI, Keil U, Anderson HR et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8:483-91.
20. Bos JD, Van Leent EJ. Sillevis Smitt JH. The millennium criteria for the diagnosis of atopic dermatitis. Exp Dermatol 1998; 7:132-8.
21. Brenninkmeijer EE, Schram ME, Leeflang MM, Bos JD, Spuls PI. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol 2008; 158:754-65.
22. Hagstromer L, Ye W, Nyren O, Emtestam L. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005; 141:1123-7.
23. Arana A, Wentworth CE, Fernandez-Vidaurre C, Schlienger RG, Conde E, Arellano FM. Incidence of cancer in the general population and in patients with or without atopic dermatitis in the U.K. Br J Dermatol 2010; 163:1036-43.
24. Arellano FM, Arana A, Wentworth CE, Fernandez-Vidaurre C, Schlienger RG, Conde E. Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. J Allergy Clin Immunol 2009; 123: 1111-6, 116.
25. Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007; 120:1389-98.
26. Barbier N, Paul C, Luger T et al. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme. Br J Dermatol 2004; 150:96-102.
27. Stalder JF, Barbarot S, Wollenberg A et al. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy 2011; 66:1114-21.
28. Schmitt J, Williams H. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol 2010; 163:1166-8.
29. Langan SM, Thomas KS, Williams HC. What is meant by a "flare" in atopic dermatitis? A systematic review and proposal. Arch Dermatol 2006; 142:1190-6.
30. Langan SM, Williams HC. What causes worsening of eczema? A systematic review. Br J Dermatol 2006; 155:504-14.
31. Darsow U, Laifaoui J, Kerschenlohr K et al. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 2004; 59:1318-25.
32. Tupker RA, De Monchy JG, Coenraads PJ, Homan A, van der Meer JB. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 1996; 97:1064-70.
33. Brinkman L, Aslander MM, Raaijmakers JA, Lammers JW, Koenderman L, Bruijnzeel-Koomen CA. Bronchial and cutaneous responses in atopic dermatitis patients after allergen inhalation challenge. Clin Exp Allergy 1997; 27:1043-51.
34. Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996; 347:15-8.
35. Holm L, Bengtsson A, Hage-Hamsten M, Ohman S, Scheynius A. Effectiveness of occlusive bedding in the treatment of atopic dermatitis-a placebo-controlled trial of 12 months' duration. Allergy 2001; 56:152-8.
36. Oosting AJ, Bruin-Weller MS, Terreehorst I et al. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J Allergy Clin Immunol 2002; 110:500-6.
37. Gutgesell C, Heise S, Seubert S et al. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis. Br J Dermatol 2001; 145:70-4.
38. Werfel T, Breuer K, Rueff F et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy 2006; 61:202-5.
39. Novak N, Thaci D, Hoffmann M et al. Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract-a new therapeutic option for patients with atopic dermatitis. Int Arch Allergy Immunol 2011; 155:252-6.
40. Werfel T, Ballmer-Weber B, Eigenmann PA et al. Eczematous reactions to food in atopic eczema: position paper of the EAACI and GA2LEN. Allergy 2007; 62:723-8.
41. Reekers R, Busche M, Wittmann M, Kapp A, Werfel T. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol 1999; 104:466-72.
42. Bath-Hextall F, Delamere FM, Williams HC. Dietary exclusions for established atopic eczema. Cochrane Database Syst Rev 2008; 1:CD005203.
43. Bath-Hextall F, Delamere FM, Williams HC. Dietary exclusions for improving established atopic eczema in adults and children: systematic review. Allergy 2009; 64:258-64.
44. Russell SC, Dawe RS, Collins P, Man I, Ferguson J. The photosensitivity dermatitis and actinic reticuloid syndrome (chronic actinic dermatitis) occurring in seven young atopic dermatitis patients. Br J Dermatol 1998; 138:496-501.
45. ten Berge O, van Weelden H, Bruijnzeel-Koomen CA, de Bruin-Weller MS, Sigurdsson V. Throwing a light on photosensitivity in atopic dermatitis: a retrospective study. Am J Clin Dermatol 2009; 10:119-23.
46. Cho SH, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 2001; 108:269-74.
47. Gong JQ, Lin L, Lin T et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol 2006; 155:680-7.
48. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974; 90:525-30.
49. Matsui K, Nishikawa A, Suto H, Tsuboi R, Ogawa H. Comparative study of Staphylococcus aureus isolated from lesional and non-lesional skin of atopic dermatitis patients. Microbiol Immunol 2000; 44:945-7.
50. Boguniewicz M, Leung DY. Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 2010; 125:4-13.
51. Reginald K, Westritschnig K, Werfel T et al. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin Exp Allergy 2011; 41:357-69.
52. Birnie AJ, Bath-Hextall FJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev 2008; 3:CD003871.
53. Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol 2010; 163:12-26.
54. Schuttelaar ML, Coenraads PJ. A randomized, double-blind study to assess the efficacy of addition of tetracycline to triamcinolone acetonide in the treatment of moderate to severe atopic dermatitis. J Eur Acad Dermatol Venereol 2008; 22:1076-82.
55. Wollenberg A, Wetzel S, Burgdorf WH, Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 2003; 112:667-74.
56. Peng WM, Jenneck C, Bussmann C et al. Risk factors of atopic dermatitis patients for eczema herpeticum. J Invest Dermatol 2007; 127:1261-3.
57. Boguniewicz M, Schmid-Grendelmeier P, Leung DY. Atopic dermatitis. J Allergy Clin Immunol 2006; 118:40-3.
58. Broberg A, Faergemann J, Johansson S, Johansson SG, Strannegard IL, Svejgaard E. Pityrosporum ovale and atopic dermatitis in children and young adults. Acta Derm Venereol 1992; 72:187-92.
59. Darabi K, Hostetler SG, Bechtel MA, Zirwas M. The role of Malassezia in atopic dermatitis affecting the head and neck of adults. J Am Acad Dermatol 2009; 60:125-36.
60. Devos SA, van der Valk PG. The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis. Allergy 2000; 55:1056-8.
61. Back O, Scheynius A, Johansson SG. Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res 1995; 287:448-51.
62. Ikezawa Z, Kondo M, Okajima M, Nishimura Y, Kono M. Clinical usefulness of oral itraconazole, an antimycotic drug, for refractory atopic dermatitis. Eur J Dermatol 2004; 14:400-6.
63. Lintu P, Savolainen J, Kortekangas-Savolainen O, Kalimo K. Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts. Allergy 2001; 56:512-7.
64. Svejgaard E, Larsen PO, Deleuran M, Ternowitz T, Roed-Petersen J, Nilsson J. Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo. J Eur Acad Dermatol Venereol 2004; 18:445-9.
65. Hwang CY, Chen YJ, Lin MW et al. Prevalence of atopic dermatitis, allergic rhinitis and asthma in Taiwan: a national study 2000 to 2007. Acta Derm Venereol 2010; 90:589-94.
66. Bousquet J, Khaltaev N, Cruz AA et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63(Suppl. 86):8-160.
67. Wuthrich B, Schmid-Grendelmeier P. Natural course of AEDS. Allergy 2002; 57:267-8.
68. Novembre E, Cianferoni A, Lombardi E, Bernardini R, Pucci N, Vierucci A. Natural history of "intrinsic" atopic dermatitis. Allergy 2001; 56:452-3.
69. van der Hulst AE, Klip H, Brand PL. Risk of developing asthma in young children with atopic eczema: a systematic review. J Allergy Clin Immunol 2007; 120:565-9.
70. Jay JL. Clinical features and diagnosis of adult atopic keratoconjunctivitis and the effect of treatment with sodium cromoglycate. Br J Ophthalmol 1981; 65:335-40.
71. Garrity JA, Liesegang TJ. Ocular complications of atopic dermatitis. Can J Ophthalmol 1984; 19:21-4.
72. Tuft SJ, Kemeny DM, Dart JK, Buckley RJ. Clinical features of atopic keratoconjunctivitis. Ophthalmology 1991; 98:150-8.
73. Werfel T, Breuer K. Role of food allergy in atopic dermatitis. Curr Opin Allergy Clin Immunol 2004; 4:379-85.
74. Worth A, Sheikh A. Food allergy and atopic eczema. Curr Opin Allergy Clin Immunol 2010; 10:226-30.
75. Worm M, Forschner K, Lee HH et al. Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. Acta Derm Venereol 2006; 86:119-22.
76. Prasad GA, Alexander JA, Schleck CD et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County. Minnesota. Clin Gastroenterol Hepatol 2009; 7:1055-61.
77. Schoepfer AM, Simon D, Straumann A. Eosinophilic oesophagitis: latest intelligence. Clin Exp Allergy 2011; 41:630-9.
78. Straumann A, Aceves SS, Blanchard C et al. Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 2012; 67:477-90.
79. Al-Niaimi F, Yell J. An increasingly recognized cause of dysphagia in patients with severe atopic dermatitis. Clin Exp Dermatol 2011; 36:206-7.
80. Dotterud LK, Smith-Sivertsen T. Allergic contact sensitization in the general adult population: a population-based study from Northern Norway. Contact Dermatitis 2007; 56:10-5.
81. Ponyai G, Hidvegi B, Nemeth I, Sas A, Temesvari E, Karpati S. Contact and aeroallergens in adulthood atopic dermatitis. J Eur Acad Dermatol Venereol 2008; 22:1346-55.
82. de Groot AC. The frequency of contact allergy in atopic patients with dermatitis. Contact Dermatitis 1990; 22:273-7.
83. Heine G, Schnuch A, Uter W, Worm M. Type-IV sensitization profile of individuals with atopic eczema: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). Allergy 2006; 61:611-6.
84. Vind-Kezunovic D, Johansen JD, Carlsen BC. Prevalence of and factors influencing sensitization to corticosteroids in a Danish patch test population. Contact Dermatitis 2011; 64:325-9.
85. Sicherer SH, Sampson HA. Food allergy. J Allergy Clin Immunol 2010; 125(2 Suppl. 2):S116-25.
86. Knol EF, Knulst AC. Application of multiplexed immunoglobulin E determination on a chip in component-resolved diagnostics in allergy. Clin Exp Allergy 2010; 40:190-2.
87. Nicolaou N, Custovic A. Molecular diagnosis of peanut and legume allergy. Curr Opin Allergy Clin Immunol 2011; 11:222-8.
88. Turjanmaa K, Darsow U, Niggemann B, Rance F, Vanto T, Werfel T. EAACI/GA2LEN position paper: present status of the atopy patch test. Allergy 2006; 61:1377-84.
89. Haeck IM, Hamdy NA, Timmer-de ML et al. Low bone mineral density in adult patients with moderate to severe atopic dermatitis. Br J Dermatol 2009; 161:1248-54.
90. Searing DA, Leung DY. Vitamin D in atopic dermatitis, asthma and allergic diseases. Immunol Allergy Clin North Am 2010; 30:397-409.
91. Schauber J, Dorschner RA, Yamasaki K, Brouha B, Gallo RL. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 2006; 118:509-19.
92. Miller J, Gallo RL. Vitamin D and innate immunity. Dermatol Ther 2010; 23:13-22.
93. Ong PY, Ohtake T, Brandt C et al. Endogenous antimicrobial peptides and skin infections in atopic der-matitis. N Engl J Med 2002; 347:1151-60.
94. Schauber J, Oda Y, Buchau AS et al. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1, 25-dihydroxyvitamin D3. J Invest Dermatol 2008; 128:816-24.
95. Hata TR, Kotol P, Jackson M et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 2008; 122:829-31.
96. Peroni DG, Piacentini GL, Cametti E, Chinellato I, Boner AL. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol 2011; 164:1078-82.
97. Sidbury R, Sullivan AF, Thadhani RI, Camargo CA Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol 2008; 159:245-7.
98. Javanbakht MH, Keshavarz SA, Djalali M et al. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatolog Treat 2011; 22:144-50.
99. Wittkowski A, Richards HL, Griffiths CE, Main CJ. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J Psychosom Res 2004; 57:195-200.
100. Linnet J, Jemec GB. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 1999; 140:268-72.
101. Fivenson D, Arnold RJ, Kaniecki DJ, Cohen JL, Frech F, Finlay AY. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm 2002; 8:333-42.
102. Holm EA, Esmann S, Jemec GB. The handicap caused by atopic dermatitis-sick leave and job avoidance. J Eur Acad Dermatol Venereol 2006; 20:255-9.
103. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19:210-6.
104. de Bruin Weller MS, Knulst AC, Meijer Y, Bruijnzeel-Koomen CA, Pasmans SG. Evaluation of the child with atopic dermatitis. Clin Exp Allergy 2012;42:352-62.